Skip to main content
Emerging Microbes & Infections logoLink to Emerging Microbes & Infections
. 2021 Jun 13;10(1):1169–1179. doi: 10.1080/22221751.2021.1932606

Extracellular acidosis enhances Zika virus infection both in human cells and ex-vivo tissue cultures from female reproductive tract

A Varese a,*, E Dantas a,*, A Paletta a, W Fitzgerald b, F Di Diego García a, G Cabrerizo a, F Erra Diaz a, L A Defelipe c,, H Pallares d, M Dodes Traian c, A Gamarnik d, J Geffner a, F Remes Lenicov a, L Margolis b,*, A Ceballos a,*,CONTACT
PMCID: PMC8205022  PMID: 34013833

ABSTRACT

Zika virus (ZIKV) is a flavivirus transmitted by mosquitoes of the genus Aedes, but unlike other flaviviruses, ZIKV can be sexually transmitted by vaginal intercourse. The healthy vaginal pH ranges from 4.0 to 6.0, reaching values of 6.0–7.0 after semen deposition. Here, we report that low extracellular pH values (range 6.2–6.6) dramatically increase ZIKV infection on cell lines of different origin including some derived from the female genital tract and monocyte-derived macrophages. Furthermore, low pH significantly increased ZIKV infection of human ectocervix and endocervix cultured ex-vivo. Enhancement of infection by low pH was also observed using different ZIKV strains and distinct methods to evaluate viral infection, i.e. plaque assays, RT–PCR, flow cytometry, and fluorescence microscopy. Analysis of the mechanisms involved revealed that the enhancement of ZIKV infection induced by low pH was associated with increased binding of the viral particles to the heparan sulphate expressed on the target cell surface. Acidosis represents a critical but generally overlooked feature of the female genital tract, with major implications for sexual transmission diseases. Our results suggest that low vaginal pH might promote male-to-female transmission of ZIKV infection.

KEYWORDS: ZIKV, extracellular acidosis, sexual transmission, heparan sulphate, ex-vivo tissues

Introduction

Zika virus (ZIKV) is an emerging pathogen associated with neurodevelopmental defects in foetuses, and a neurological syndrome in adults [1–4]. ZIKV is primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes, but sexual transmission has also been documented [5–10]. This has challenged the paradigm of arbovirus–host interactions opening new questions regarding the transmission of ZIKV infection.

Symptomatic ZIKV infection usually results in a mild and self-limiting febrile disease, although different reports have suggested a possible association with more serious conditions such as Guillain–Barré syndrome, and microcephaly in new-born infants from mothers infected with ZIKV during pregnancy [1–4]

Male-to-female, male-to-male, and female-to-male ZIKV sexual transmission have been reported [5–10]. Viral load in semen reaches titters up to 100,000 times higher than in blood and persists for up to six months after infection [11,12]. In addition, ZIKV in semen samples was shown to be able to productively infect Vero cells [13]. Moreover, a close association of ZIKV with the spermatozoa head has been reported [6].

Male-to-female transmission requires that ZIKV successfully resist vaginal acidosis [13,14]. Large areas of the mucosal surfaces of the genital tract are exposed to low pH values. The healthy vaginal environment is characterized by acidic values of pH between 4.0 and 6.0 [13,14]. In contrast, the pH of normal semen is slightly alkaline ranging from 7.2 to 7.8 [15]. Upon semen deposition, the vaginal environment can reach pH values ranging from approximately pH 6.0 to 7.0 for several hours after sexual intercourse [16,17], thus exposing ZIKV to a broad range of pH values.

Heparan sulphate (HS), a linear polysaccharide found in almost all tissues, has been identified as an important attachment factor for several viruses [18–28]. Previous studies have shown that ZIKV interacts with cell surface HS [29–32]. The interactions between some flavivirus, for example, dengue and yellow fever, and cell surface HS are required to concentrate virus particles at the cell surface and to facilitate binding to a second receptor specifically recognized by the viral envelope protein. Therefore, viral production was reduced when HS was desulfated or enzymatically removed from the cell surface [28].

ZIKV is the only flavivirus capable of being sexually transmitted, therefore, we hypothesized that ZIKV would be able to preserve infectivity under low values of extracellular pHs, such as those found in the female genital tract. Surprisingly, we found that acidosis not only preserves, but dramatically increases ZIKV’s ability to infect cell lines and ex-vivo tissue cultures derived from the female genital tract, as well as monocyte-derived macrophages (MDM) and primary astrocytes (NHA). Furthermore, we found that this enhancing effect is mediated by increased binding of viral particles to heparan sulphate (HS) expressed on the target cell surface.

Materials and methods

Viruses

ZIKV Senegal 1985 isolate (DAK-AR-41524_A1C1-V2, GeneBank accession no KX198134) was gifted by Dr A. Gamarnik. ZIKV Venezuela was isolated from a patient who travelled from Venezuela to Argentina in 2015 (strain ARCB116141, GeneBank accession no. MK637519) and gifted by Instituto Nacional de Enfermedades Virales Humanas “Dr Julio I. Maiztegui” (INEVH). ZIKV Puerto Rico 2015 Isolate (PRVABC59, GeneBank accession no KU501215) was gifted by Dr Viviana Castilla and the University of Buenos Aires, School of Sciences. ZIKV VR-1844 strain was acquired from ATCC. DENV-2 was a gift from Dr Andrea Gamarnik and was obtained by transfection of an in vitro transcribed RNA from the infectious DENV-2 cDNA clone pD2-IC 30-PA [33], originally isolated from a patient with dengue haemorrhagic fever (Asian genotype). All the viruses were propagated and titrated in Vero cells, and the infectious titer was expressed as pfu per ml. All infections were carried out using Senegal strain except where indicated.

Cell lines and primary culture

VERO C1008 (clone E6, ATCC® CRL-1586™), HESC-T (ATCC® CRL-4003™) cells, and Normal Human Astrocytes (NHA, LONZA) were cultured in DMEM (Thermo Fisher) supplemented with 10% heat-inactivated foetal bovine serum (FBS, Thermo Fisher), penicillin (100 U/ml), and streptomycin (100 µg/ml). VK-2/E6E7 (ATCC® CRL-2616™), ECT-1/E6E7 (ATCC® CRL-2614™), and END-1/E6E7 (ATCC® CRL-2615™) cell lines were purchased from the American Type Culture Collection and cultured in Keratinocyte-Serum Free medium (GIBCO-BRL 17005-042) with 0.1 ng/ml human recombinant EGF, 0.05 mg/ml bovine pituitary extract, and additional calcium chloride 44.1 mg/l. Human monocyte was obtained from healthy donors by Percoll-Hypaque gradient and differentiated to monocyte-derived macrophages (MDM) with M-CSF for 5 days, or to monocyte-derived dendritic cells (DCs) with 10 ng/ml GM-CSF and 10 ng/ml of IL-4 for 5 days. Purity and differentiation were monitored by flow cytometry analysis prior to each experiment.

Ex-vivo tissue culture of ectocervix and endocervix

Cervico-vaginal surgical pieces were obtained through the National Disease Research Interchange (Philadelphia, PA) according to IRB-approved protocols. Ecto- and endocervical tissues were dissected into 2-mm [3] blocks and incubated in 2 ml Eppendorf tubes (cat no. EP022363344) with ZIKV (VR-1844; moi 0.1) in DMEM adjusted to pH 7.3 or 6.2 for 1 h at 37°C. After two washes with PBS the tissue pieces were placed on top of Gelfoam pads sponges in DMEM with 10% FBS and incubated at 37°C as previously described [34].

Cell viability assays

Apoptosis and necrosis were evaluated by staining with annexin-FITC/propidium iodide (BD Biosciences) by flow cytometry. Cells were labelled with annexin-V FITC and propidium iodide for 15 min at room temperature and analysed by flow cytometry using a BD FACSCanto cytometer and BD FACSDiva software (BD Biosciences). MTT reduction assay was performed on Vero cells following the manufacturer’s instructions (Merck).

Viral infections and binding

Infections (moi = 0.1) were performed in serum-free RPMI (Thermo Fisher) supplemented with HEPES (10 mM) (Thermo Fisher) for 1 h at 37°C, 5% CO2, and pH values were adjusted using isotonic hydrochloric acid. After the infection, the supernatant was retrieved, pH values were reassessed, and cells were washed and placed in a culture medium. For binding assays, cells were incubated with the viral inoculum at different pH values at 4°C for 1 h and immediately after cells were washed four times with PBS, and RNA was extracted. NH4Cl treatment on Vero cells consisted of a pre-incubation of 1.5 h with 2, 20 and 100 mM of NH4Cl in RPMI 2% FBS. During the infection, pH was adjusted in RPMI with the corresponding concentration of NH4Cl. After 1 h cells were washed and infection was assessed after 48 h.

To abrogate HS synthesis, Vero cells were cultured for 72 h with 25 mM sodium chlorate in a custom-made Dulbecco modified Eagle medium lacking sulphate supplemented with 10% foetal calf serum, as described previously [35]. For enzymatic removal of HS, Vero cells were treated with 5 U/ml of a heparinase I and III blends (Sigma) for 2 h at 37°C.

Intracellular pH measurement

Intracellular pH measurement was performed using BCECF-AM as previously described [36]. Briefly, Vero (5 × 106 /ml) were loaded in PBS with 1 μg/ml BCECF-AM for 15 min at 37°C, washed in PBS, and resuspended in culture medium, adjusted to different pH values, in the absence or presence of NaHCO3. Immediately after, the values of intracellular pH for each condition were determined. The analysis was performed by flow cytometry, with excitation at 488 nm and emission analysis at FL1 and FL3. The intracellular pH was calculated from the ratio of emission intensities at the two wavelengths, standardizing by comparison with the fluorescence intensity ratios of cells whose intracellular pH values were fixed by incubation with nigericin (10 μM) in a high-potassium buffer.

Viral detection by qPCR

Total RNA was obtained from 3 × 106 previously washed cells lysed using a Pure-link Viral RNA DNA extraction kit following the manufacturer’s instructions (Thermo Scientific). Reverse transcription was carried out using Moloney murine leukaemia virus reverse transcriptase (Invitrogen) according to the manufacturer’s instructions. In brief, 5 µg of RNA were incubated for 50 min at 37°C in the presence of 200 ng random decamer primers (Invitrogen) and 10 mM dNTP mix. Quantitative real-time PCR was performed using SYBR Green PCR Master Mix (Invitrogen) in a 20-µl reaction. Both ZIKV and DENV genomes were detected using 200 nM of primers 5- GCCGCCACCAAGATGAACTGATTG -3 (forward) and 5- GCAGTCTCCCGGATGCTCCATC -3 (reverse). Reactions were carried out in StepONE Plus cycler (Thermo Scientific). The cycling programme used was 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. Data were analysed by the ΔΔCt method using GADPH as the reference gene.

Luminex assay

When indicated, ZIKV infection was assessed measuring NS1 production by Luminex. Briefly, magnetic carboxylated microspheres (Luminex) were coated by two-step carbodiimide coupling with an antibody against NS1 (Fitzgerald, cat no. 10-2707). The standard curve was obtained by serial dilution of recombinant NS1 protein (Fitzgerald, cat no. 30-1931). For detection, an anti-NS1 antibody (Abcam cat no. 218546) was biotinylated using the EZ-Link Sulfo-NHS-Biotin (Thermo Scientific cat no. 21217). Streptavidin conjugated with R-Phycoerythrin (Thermo Scientific cat no. S866) was used to detect the biotinylated antibody. All experiments were acquired using a Bio-Rad Bio-Plex 200 System and analysed with the Bio-Plex Manager software.

Flow cytometry and microscopy

For ZIKV detection rabbit pan-flavivirus anti-E (clone 4G2, Absolute Antibody) was used as a primary antibody and FITC conjugated anti-rabbit secondary was used for detection. Heparan sulphate (HS) expression was determined using the clone F58-10E4 (Amsbio) as a primary antibody and an anti-mouse IgM as a secondary antibody. Isotype-matched control antibodies were used, and a gate (R1) was defined in the analysis to exclude non-viable cells and debris, based on size and propidium iodine staining. Analyses were performed using a FACS flow cytometer (FACS CANTO I, Becton Dickinson) and the data were analysed using FlowJo software (Tree Star, Inc.).

For microscopy, Vero cells were fixed and permeabilized with methanol 20 min at 4°C, then stained with rabbit pan-flavivirus anti-E (clone 4G2, Absolute Antibody) as a primary antibody, and FITC conjugated anti-rabbit secondary was used for detection. Cells were mounted with Fluoroshield (Sigma Aldrich) containing DAPI and images were acquired using a confocal microscope (Zeiss Ism 880).

For Ki67 immunofluorescence (IF), Vero cells were fixated with 4% PFA and permeabilized with 0.3% Triton X-100. After blocking with 5% donkey serum (Sigma, cat.no. D9663-10ML) cells were stained with an anti- Ki67 (NB600-1252) as primary antibody and an anti-rabbit conjugated to Alexa-488 (Jackson ImmunoResearch) as a secondary antibody. The slides were mounted using a mounting medium with DAPI (Vector laboratories, cat no. H-1200-10). Images were acquired with a Nikon TI Eclipse microscope and quantified using QuPath 0.2.3.

Statistics

Student paired t-test, One or two-way ANOVA were used to determine the significance of differences between groups. Multiple analyses were followed by Bonferroni’s multiple-comparison post-test. P-values < 0.05 were considered statistically significant.

Results

Low extracellular pH strongly enhances ZIKV infection.

In the first set of experiments, we evaluated the impact of extracellular pH on ZIKV infection. Vero cells were incubated with ZIKV for 60 min in media adjusted to pH values of 7.2 (control), 7.0, 6.8, 6.6, 6.4, 6.2, 6.0, and 5.8; then cells were washed to remove the viral inoculum and a fresh medium was added (pH 7.3). Forty-eight hours later, the titters of infectious ZIKV were evaluated by plaque assays and expressed as plaque-forming units per millilitre (pfu/ml) (Figure 1(A)). Our results showed that pH values ranging between 5.8 and 6.6 markedly enhanced ZIKV infection, reaching a maximum effect at pH 6.2 (Figure 1(A,B). Similar results were observed when ZIKV infection was evaluated by NS5 ZIKV RNA expression (Figure 1(C)), fluorescence microscopy (Figure 1(D)), and analysis of intracellular ZIKV E protein expression by flow cytometry (Figure 1(E)). No changes in cell viability, metabolic activity (i.e. MTT reduction), and cell proliferation were observed in the range of pH tested (Supplementary Figure 1(A–C)).

Figure 1.

Figure 1

. Low extracellular pH enhances ZIKV infection of Vero cells. (A–E) Vero cells were incubated with ZIKV (A1C1-V2) for 1 h at different values of pH (moi 0.01). Then, cells were washed twice and ZIKV infection was analysed 48 h later in cell supernatants by pfu assays (A, B), qPCR (C), immunofluorescence (D), and flow cytometry using an anti-Env mAb (E). (F) Vero cells were incubated at pH 7.3 or 6.2 for 1 h at 37°C (moi 0.01) with different strains of ZIKV (Senegal, Venezuela or Puerto Rico isolates). Viral production was quantified in cell supernatants at days 1, 2 and 3 post-infection (p.i.). (G) Vero cells were incubated as described above with ZIKV (SEN) produced either in Vero cells or C6/36 cells. After 48 h, viral load was measured by qPCR. (H) Vero cells were incubated with ZIKV (moi 0.01) or with DENV-2 (moi 0.1), as described above. After 48 h, viral load was measured by qPCR. Data in A, D, E, F, G, and H are representative of three different experiments. Results in B and C were obtained in five independent experiments. Results are presented as mean ± SEM (B, C, D, G, H) and mean ± SD (A, F).

We also analysed whether the higher infectivity observed at low pH was reproduced using different ZIKV strains: African isolate (Senegal, 1985) and American isolates (Venezuela and Puerto Rico, 2015). Productive viral infection was assessed by quantifying infectious virus in supernatants collected from day 1 to day 3 post-infection. All ZIKV strains analysed showed increased productive infection at pH 6.2 compared to pH 7.3 (Figure 1(F)). Similar results were also observed using viral stocks produced either in mosquito- or primate-derived cell lines (C6/36 and Vero respectively) (Figure 1(G)).

Next, we tested whether low pH might also increase the infection of the Dengue virus (DENV-2), which is closely related to ZIKV. Vero cells were inoculated in parallel experiments with ZIKV or DENV-2 at different values of pH for 60 min, washed, and cultured at pH 7.3 for 48 h. Then, viral RNA expression was measured by qPCR. We observed that low pH did not increase DENV infection (Figure 1(H)).

To evaluate whether acidosis also increased ZIKV infection of cells derived from the female reproductive tract, vaginal (VK2/E6E7) ectocervical (Ect1/E6E7), and endocervical (End1/E6E7) cell lines and human-derived endometrial fibroblasts (T-HESC) were inoculated with ZIKV at pH values of 7.3, 6.6, and 6.2 for 1 h at 37°C. Cells were then washed, cultured for 48 h in fresh media (pH: 7.3), and evaluated for ZIKV infection. Figure 2(A–D) shows that infection was markedly increased at pH 6.2 compared to neutral pH. No changes in cell viability were observed in the range of pH tested (data not shown). Moreover, the enhancing effect of low pH on ZIKV infection was also observed using human monocyte-derived macrophages (MDM) and primary astrocytes (NHA) (Figure 2(E,F)). Of note, ZIKV infection enhancement by low pH is not reproduced in monocyte-derived dendritic cells (Supplementary Figure 2(A–C))

Figure 2.

Figure 2.

Acidosis enhances ZIKV infection in cells derived from the female reproductive tract and other target cells. Cells were incubated with ZIKV (A1C1-V2) at different pH values for 1 h at 37°C. Then, cells were washed and infection was assessed 72 h later. Infection of genital tract-derived cells VK2/E6E7 (A), Ect1/E6E7 (B), and End1/E6E7 (C) was quantified by measuring the extracellular concentration of NS-1 by Luminex. Infection of human endometrial fibroblasts (T-HESC) was quantified by qPCR (D). Infection of monocyte-derived macrophages (MDM) was quantified by measuring the extracellular concentration of NS-1 by Luminex (E). Primary culture-derived human astrocytes (NHA) infection was measured by qPCR (F). Human ectocervical (G) and endocervical (H) tissue cultures were dissected into 2 mm [3] pieces and infected with ZIKV (VR-1844 moi 0.1) either at pH 7.3 or 6.2 for 1 h at 37°C. The viral production was evaluated at days 3, 6, 10, 13, 17, and 21 by measuring ZIKV NS1 in the culture supernatant. Results in A, B, C, D, and F represent data of two independent experiments. Data in E comprises the results of four different donors. Panels H and G were constructed with data of three independent experiments per explant type, and data were analysed using paired two-way ANOVA. Results are presented as mean ± SEM.

To demonstrate our hypothesis in a more physiologically relevant scenario, we performed experiments using a well-established technique for culturing and infecting ectocervical and endocervical tissues ex-vivo [34]. Human cervical tissues were dissected into 2 mm [3] pieces and infected with ZIKV either at pH 7.3 or 6.2 for 1 h at 37°C. The viral production was evaluated at days 3, 6, 10, 13, 17, and 21 by measuring ZIKV NS1 in the culture supernatant. Consistently, both endocervix and ectocervix explants produce a significant increase in viral titters when infected at pH 6.2, showing that the extracellular acidosis enhances ZIKV infection in tissues from the human female genital tract ex-vivo.

Low extracellular pH increases ZIKV binding to target cells.

We then evaluated whether the promotion of ZIKV infection induced by low pH was related to increased binding of viral particles to the target cell surface. In these experiments, Vero cells were incubated with ZIKV at pH values of 7.3, 6.6, and 6.2 for 1 h at 4°C or 37°C respectively. Then, cells were washed and cell-associated viruses were quantified by qPCR. We found that low pH markedly promoted the association of viral particles with Vero cells in assays performed at either 4°C or 37°C (Figure 3(A)). Similar results were observed in assays carried out with MDM or VK2/E6E7 cells (Figure 3(B,C)). These findings suggest that the enhanced binding of viral particles to the target cell surface, and no other early events that might occur at 37°C such as promotion of virus fusion, might be responsible for the enhanced effect induced by low pH on ZIKV infectivity. Supporting this, a marked increase in viral production was observed when Vero cells were incubated with ZIKV at pH 6.2 for 1 h at 4°C and after thoroughly washing they were cultured at neutral pH for 48 h (Figure 3(D)). By contrast, when Vero cells were incubated with ZIKV at pH 7.3 for 1 h at 4°C and after washing, cells were cultured for an additional hour at pH 6.2, washed again and cultured at neutral pH for 48 h, no promotion of infection was observed (Figure 3(E)). Interestingly, and in contrast to ZIKV, low pH did not increase the binding of DENV-2 to Vero cells (Figure 3(F)). We conclude that low pH enhances ZIKV infection, at least in part, by increasing the binding of viral particles to the cell surface. Because low pH has shown to induce irreversible changes in viral-surface proteins of a number of viruses in order to facilitate virus fusion with endosomal membranes [37–39], we analysed whether a transient exposure of ZIKV to low pH was able to promote viral infectivity. As shown in Figure 3(G), no changes in the infection pattern were observed when ZIKV was pre-incubated at low pH before Vero cell infection. Similar results were observed in assays performed in VK2/E6E7 cells (Figure 3(H)).

Figure 3.

Figure 3.

Low extracellular pH increases ZIKV binding to target cells. Vero cells (A), VK2/E6E7 cells (B), or MDM (C) were incubated with ZIKV (A1C1-V2; moi 0.01) for 1 h at 37°C or 4°C, at different pH values. Then, cells were washed four times and total RNA was extracted to determine ZIKV binding by qPCR. Vero cells were incubated at different pH values with ZIKV (moi 0.01) for 1 h at 4°C, at different pH values. Then, cells were washed and cultured at neutral pH for 48 h. Viral production was quantified by pfu (D). Vero cells were cultured with ZIKV (moi 0.01) at pH 7.3 for 1 h at 37°C, washed, and incubated for 1 h at different pH values. Then, cells were washed again and cultured for 48 h at pH 7.3. Viral production was determined by pfu (E). DENV-2 and ZIKV binding to Vero cells were assessed in parallel as described above (F). ZIKV suspensions were pre-incubated at pH 7.3 or 6.2 for 1 h at 37°C. Then, the viral suspensions at pH 6.2 were neutralized back to pH 7.3 (6.2→7.3) or not, and Vero (G) and VK2 cells (H) were infected with these viral suspensions at pH 7.3 or 6.2. (I) Vero cells were pre-incubated for 1.5 h with 2, 20 and 100 mM of NH4Cl. Then ZIKV infections were performed in pH adjusted media with 2, 20, or 100 mM of NH4Cl respectively. Viral production was evaluated 48 h post-infection by pfu assay. (J) Vero cells were infected for 1 h in pH adjusted NaHCO3-free or NaHCO3 rich DMEM. ZIKV infection was quantified by pfu 48 h after infection. In parallel, BCECF-AM pre-loaded vero cells were treated with pH adjusted bicarbonate-free DMEM and intracellular pH was determined by flow cytometry. Results are expressed as the mean ± SEM of three independent experiments.

To further support the idea that low extracellular pH affects mainly ZIKV binding to cells, we performed a set of experiments exploiting the fact that NH4Cl inhibits the endosomal acidification necessary for viral fusion. We infected Vero cells in the presence of increasing concentrations of NH4Cl (2, 20, and 100 mM) at pH values of 7.3 or 6.2 and we found that even when viral fusion is being inhibited, low extracellular pH still induces an enhancement of viral infection, suggesting that acidosis exerts it’s effect upstream of viral fusion (Figure 3(I)).

In addition, as extracellular pH modification affects intracellular pH, we performed assays with NaHCO3-free media, taking advantage of the fact that NaHCO3 is necessary to equilibrate intracellular and extracellular pH. Interestingly, ZIKV infection was enhanced at pH 6.2 in NaHCO3-free media as it occurs in NaHCO3 rich media (Figure 3(J)). In parallel, we measured intracellular pH to show that in the absence of NaHCO3, extracellular pH variations do not modify intracellular pH. These data further point that acidosis in the extracellular compartment is responsible for enhancing ZIKV infection.

Extracellular acidosis enhances ZIKV binding to cell surface heparan sulphate.

Previous studies have shown that ZIKV interacts with cell surface heparan sulphate (HS) [29–31], enabling virus attachment to a variety of target cells including Vero [30], placental and brain cells [29]. To analyse whether the enhanced binding of ZIKV to target cells is dependent on HS expression, we performed a new set of experiments in conditions in which the expression of HS was inhibited [35]. First, we observed that HS surface expression in Vero cells was not modified by incubation for 1 h at low pH values compared to neutral pH (7.3) (Figure 4(A)). Then, Vero cells were cultured for three days in a sulphate-free medium supplemented with sodium chlorate, an inhibitor of sulphation. As we previously shown [40], this treatment resulted in a marked reduction (> 90%) in the expression cell surface HS (data not shown). These cells were incubated with ZIKV at pH 7.3 or 6.2 for 1 h, washed, and incubated for 48 h at 37°C. Then, infection was revealed by qPCR. A remarkable inhibition of infection was observed in cells challenged at low pH. In fact, under these experimental conditions, no differences were observed in the infection levels for cells challenged at either, pH 7.3 or pH 6.2 (Figure 4(B)).

Figure 4.

Figure 4.

Enhancement of ZIKV infection by low pH depends on the expression of heparan sulfate by target cells. Vero cells were incubated for 1 h in pH adjusted media and 24 h later heparan sulfate expression was determined by flow cytometry (A). Vero cells were cultured for 3 days in sulfate-free media supplemented with sodium chlorate. Then, cells were challenged with ZIKV (A1C1-V2) for 1 h at 37°C, either at pH 7.3 or 6.2, and infection was analysed by qPCR 48 h later (B). Vero cells were challenged with ZIKV at pH 7.3 or 6.2 for 1 h at 37°C, in the absence (C: control) or presence of heparin (HP). Then, cells were washed and cultured for 48 h at pH 7.3 and infection was analysed (C). Vero cells were challenged with ZIKV at pH 7.3 or 6.2 for 1 h at 4°C, in the absence (C: control) or presence of heparin (HP). Thr binding of ZIKV to Vero cells was then analysed by qPCR (D). Vero cells were treated with heparinases for 2 h at 37°C and then infected either at pH 7.3 or 6.2. Forty-eight hours later infection was analysed by pfu assay (E). Results are expressed as the mean ± SEM of three independent experiments. ns, not significant.

Heparin has a similar molecular structure to HS and it is frequently used to assess the role of cell surface HS in viral infections. Heparin has been previously shown to inhibit the infection of different target cells by flaviviruses, including yellow fever virus, dengue, and Japanese encephalitis virus in Vero cells [41–43]. However, Young Kim et al. [30] demonstrated that heparin slightly promoted ZIKV replication, in a concentration-dependent manner in assays performed at neutral pH. We found that heparin slightly inhibited the infection of ZIKV particles to Vero cells at neutral pH while it exerted a dramatic inhibition of ZIKV viral production at low pH. Moreover, at pH 6, ZIKV binding to Vero cells was also inhibited by heparin. By contrast, heparin did not inhibit the binding of ZIKV to Vero cells at neutral pH (Figure 4(C,D).

To evaluate the specific role of HS and to distinguish it from other glycosaminoglycans, such as dermatan sulphate, Vero cells were first treated with a mixture of heparinases I and III [40,44], and then infected at pH 7.3 or 6.2. Enzymatic removal of HS with heparinases significantly prevented the infection when cells were infected at low pH (Figure 4(E)). Overall, our data show an important role for HS in ZIKV infection at low pH values.

Discussion

We report for the first time that acidic values of pH markedly increase ZIKV infection in cells derived from the female genital tract, macrophages, and astrocytes. Consistently, low pH also increased ZIKV infection of human ectocervix and endocervix cultured ex-vivo. The effect imprinted by extracellular acidosis on ZIKV infection was shown to be strain independent as it was reproduced using three geographically different ZIKV isolates. Moreover, it was also observed using viral stocks obtained from either A. albopictus derived cell line C6/36 or Vero cells that differ in their glycosylation pattern [45]. Because the vaginal mucosa features low pH values, even after semen deposition [13,16,17], our observations suggest it represents a permissive environment for ZIKV infection. Of note, enhancement of infection by low extracellular pH was not observed for Dengue virus infection, another virus from the Flaviviridae family.

A previous study showed that ZIKV has the highest infectivity when viral particles were treated at pH 9 for 10 min before infection at neutral pH [46], however, under our experimental conditions, ZIKV infection was similar at pH values of 8, 9, and 7.3 (neutral pH) (data not shown). Moreover, this report shows that 10 min at pH 6 partially inactivates ZIKV viral stocks. Different times of exposition to pH and/or interaction with target cells at different pH could be explaining these contrasting results. It is also possible that this is a particularity of the strain (MR 766) the authors used.

The infectious cycle of ZIKV starts with its binding to cellular receptors and attachment factors. Several studies have revealed that ZIKV and DENV share various cell surface receptors, including Tyro3, DC-SIGN, and TIM-1 [47]. However, none of these proteins has been validated to be a unique and physiologically relevant receptor of ZIKV [48]. HS, a linear polysaccharide found in almost all tissues, has been identified as an important attachment factor for several flaviviruses, including DENV [41], JEV [27], and YFV [28]. The negative charges of the long carbohydrate chains of HS enable the interaction of HS with positive-charged groups expressed on the viral surface. In fact, HS is employed as a non-specific attachment factor by a number of viruses, including herpes simplex virus [26], Semliki forest virus [25], foot-and-mouth disease virus [24], Sindbis virus [23], Chikungunya virus [22], EV-A71 [21], human respiratory syncytial virus [20], Echoviruses [49], Rabies virus [19], Coxsackievirus [18], and Rift Valley fever virus [50]. Recently, it has been identified that HS also acts as an attachment factor in SARS-CoV-2 infection [51]. Particularly for ZIKV, using a surface plasmon resonance binding assay, Kim et al. [29] showed that the recombinant ZIKV envelope protein interacts with various glycosaminoglycans including HS. In contrast, Tan et al. [31] reported that ZIKV does not interact with heparin, a glycosaminoglycan that has similar protein binding properties to HS. Gao et al. also explored the role of HS in the interaction between ZIKV and host cells, using the CRISPR/Cas9 system to disrupt three key genes that encode proteins involved in the process of HS biosynthesis [32]. They showed that, unlike DENV-2, HS is not essential in the ZIKV entry but it appears to play a role in viral replication [32].

Our results suggest that low pH enhances ZIKV infection by favouring the interaction of viral particles with target cell HS. In fact, when target cells were cultured in conditions under which the synthesis of HS was inhibited or in the presence of heparin, the enhancing effect of low pH on viral infectivity was almost completely prevented. Moreover, the fact that a similar enhancing effect was observed when target cells and viral particles were cultured for 1 h at 4°C or 37°C suggests that low pH increases viral infectivity by promoting the binding of viral particles to the cell surface and not through energy-dependent processes such as viral fusion or endocytosis [52]. We hypothesized that low pH might increase the affinity of the ZIKV E protein to HS via protonation of histidine residues (pKa ∼ 6.5). In fact, low pH values (range 6.0–7.0) have shown to increase the binding of a variety of proteins, such as the prion protein, gp64 of baculovirus, GM-CSF, selenoprotein P, vascular endothelial growth factor, and the nonfibrillar form of a beta-amyloid peptide to HS via protonation of histidine residues [53–58]. The ability of low pH to increase the binding of viruses to target cells is not exclusive of ZIKV. We have previously reported that low pH enhances the binding of HIV-1 to spermatozoa and epithelial cells, but not to CD4+ T cells or dendritic cells [40,44].

The multistep process of membrane fusion that enables ZIKV to infect target cells is pH-induced [52]. Sun et al. [59] have demonstrated that conserved residues expressed in E protein were protonated under low pH conditions and played key roles in driving the fusion process. While low pH in endosomal compartments enables ZIKV fusion by inducing conformational changes on ZIKV E protein our results suggest that extracellular acidosis enhances the binding of the viral particles to the cell surface thus increasing viral infectivity. Together, our observations suggest that low values of pH similar to those found in the female lower genital tract after vaginal intercourse favours the sexual transmission of ZIKV infection.

Supplementary Material

Figure_for_review_2.tif
Figure_for_review_1.tif

Acknowledgments

We thank to Melina Salvatori, Carla Pascuale, María Esther Dorado, and Daniel Massa for technical assistance.

Funding Statement

This work was supported by Fondo para la Investigación Científica y Tecnológica. Ministerio de Ciencia, Tecnología e Innovación Productiva de la Nación [Grant Number PICT 2017-1038].

Disclosure statement

No potential conflict of interest was reported by the author(s).

References

  • 1.Brasil P, Calvet GA, de Souza RV, et al. . Exanthema associated with Zika virus infection. Lancet Infect Dis. 2016;16:866. [DOI] [PubMed] [Google Scholar]
  • 2.Honein MA, Dawson AL, Petersen EE, et al. . Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA. 2017;317:59–68. [DOI] [PubMed] [Google Scholar]
  • 3.Johansson MA, Mier-y-Teran-Romero L, Reefhuis J, et al. . Zika and the risk of microcephaly. N Engl J Med. 2016;375:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mlakar J, Korva M, Tul N, et al. . Zika virus associated with microcephaly. N Engl J Med. 2016;374:951–958. [DOI] [PubMed] [Google Scholar]
  • 5.Lazear HM, Diamond MS.. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J Virol. 2016;90:4864–4875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mansuy JM, Suberbielle E, Chapuy-Regaud S, et al. . Zika virus in semen and spermatozoa. Lancet Infect Dis. 2016;16:1106–1107. [DOI] [PubMed] [Google Scholar]
  • 7.Rowland A, Washington CI, Sheffield JS, et al. . Zika virus infection in semen: a call to action and research. J Assist Reprod Genet. 2016;33:435–437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stower H. Zika virus shedding in semen. Nat Med. 2018;24:702. [DOI] [PubMed] [Google Scholar]
  • 9.Deckard DT, Chung WM, Brooks JT, et al. . Male-to-male sexual transmission of Zika virus – Texas. MMWR Morb Mortal Wkly Rep. 2016;65:372–374. [DOI] [PubMed] [Google Scholar]
  • 10.Davidson A, Slavinski S, Komoto K, et al. . Suspected female-to-male sexual transmission of Zika virus – New York city. MMWR Morb Mortal Wkly Rep. 2016;65:716–717. [DOI] [PubMed] [Google Scholar]
  • 11.Mansuy JM, Pasquier C, Daudin M, et al. . Zika virus in semen of a patient returning from a non-epidemic area. Lancet Infect Dis. 2016;16:894–895. [DOI] [PubMed] [Google Scholar]
  • 12.Mansuy JM, Dutertre M, Mengelle C, et al. . Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis. 2016;16:405. [DOI] [PubMed] [Google Scholar]
  • 13.García-Closas M, Herrero R, Bratti C, et al. . Epidemiologic determinants of vaginal pH. Am J Obstet Gynecol. 1999;180:1060–1066. [DOI] [PubMed] [Google Scholar]
  • 14.Thinkhamrop J, Lumbiganon P, Thongkrajai P, et al. . Vaginal fluid pH as a screening test for vaginitis. Int J Gynaecol Obstet. 1999;66:143–148. [DOI] [PubMed] [Google Scholar]
  • 15.Harraway C, Berger NG, Dubin NH.. Semen pH in patients with normal versus abnormal sperm characteristics. Am J Obstet Gynecol. 2000;182:1045–1047. [DOI] [PubMed] [Google Scholar]
  • 16. Masters WH, Johnson VE.. The physiology of the vaginal reproductive function. West J Surg Obstet Gynecol. 1961;69:105–120. [PubMed] [Google Scholar]
  • 17.Bouvet J-P, Grésenguet G, Bélec L.. Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect. 1997;3:19–23. [DOI] [PubMed] [Google Scholar]
  • 18. Zhang X, Shi J, Ye X, et al. . Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor. Emerg Microbes Infect. 2017;6:e65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sasaki M, Anindita PD, Ito N, et al. . The role of heparan sulfate proteoglycans as an attachment factor for rabies virus entry and infection. J Infect Dis. 2018;217:1740–1749. [DOI] [PubMed] [Google Scholar]
  • 20.Feldman SA, Audet S, Beeler JA.. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol. 2000;74:6442–6447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tan CW, Poh CL, Sam I-C, et al. . Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013;87:611–620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tanaka A, Tumkosit U, Nakamura S, et al. . Genome-wide screening uncovers the significance of N-sulfation of heparan sulfate as a host cell factor for Chikungunya virus infection. J Virol. 2017;91; doi: 10.1128/JVI.00432-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Byrnes AP, Griffin DE.. Binding of Sindbis virus to cell surface heparan sulfate. J Virol. 1998;72:7349–7356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fry EE, Lea SM, Jackson T, et al. . The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 1999;18:543–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Smit JM, Waarts B-L, Kimata K, et al. . Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol. 2002;76:10128–10137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yura Y, Iga H, Kondo Y, et al. . Heparan sulfate as a mediator of herpes simplex virus binding to basement membrane. J Invest Dermatol. 1992;98:494–498. [DOI] [PubMed] [Google Scholar]
  • 27.Chen H-L, Her S-Y, Huang K-C, et al. . Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers. 2010;94:331–338. [DOI] [PubMed] [Google Scholar]
  • 28.Germi R, Crance J-M, Garin D, et al. . Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology. 2002;292:162–168. [DOI] [PubMed] [Google Scholar]
  • 29.Kim SY, Zhao J, Liu X, et al. . Interaction of Zika virus envelope protein with glycosaminoglycans. Biochemistry. 2017;56:1151–1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim SY, Koetzner CA, Payne AF, et al. . Glycosaminoglycan compositional analysis of relevant tissues in Zika virus pathogenesis and in vitro evaluation of heparin as an Antiviral against Zika virus infection. Biochemistry. 2019;58:1155–1166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tan CW, Sam I-C, Chong WL, et al. . Polysulfonate suramin inhibits Zika virus infection. Antiviral Res. 2017;143:186–194. [DOI] [PubMed] [Google Scholar]
  • 32.Gao H, Lin Y, He J, et al. . Role of heparan sulfate in the Zika virus entry, replication, and cell death. Virology. 2019;529:91–100. [DOI] [PubMed] [Google Scholar]
  • 33.Villordo SM, Filomatori CV, Sánchez-Vargas I, et al. . Dengue virus RNA structure specialization facilitates host adaptation. PLoS Pathog. 2015;11:e1004604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Grivel J-C, Margolis L.. Use of human tissue explants to study human infectious agents. Nat Protoc. 2009;4:256–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Baeuerle PA, Huttner WB.. Chlorate–a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun. 1986;141:870–877. [DOI] [PubMed] [Google Scholar]
  • 36.Chow S, Hedley D, Tannock I.. Flow cytometric calibration of intracellular pH measurements in viable cells using mixtures of weak acids and bases. Cytometry. 1996;24:360–367. [DOI] [PubMed] [Google Scholar]
  • 37.Russell CJ, Hu M, Okda FA.. Influenza hemagglutinin protein stability, activation, and pandemic risk. Trends Microbiol. 2018;26:841–853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kampmann T, Mueller DS, Mark AE, et al. . The role of histidine residues in low-pH-mediated viral membrane fusion. Structure. 2006;14:1481–1487. [DOI] [PubMed] [Google Scholar]
  • 39.Weed DJ, Pritchard SM, Gonzalez F, et al. Mildly acidic pH triggers an irreversible conformational change in the fusion domain of herpes simplex virus 1 glycoprotein B and inactivation of viral entry. J Virol. 2017;91(5):e02123-16. Published 2017 Feb 14. doi: 10.1128/JVI.02123-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Dantas E, Erra Díaz F, Pereyra Gerber P, et al. Histidine-Rich glycoprotein inhibits HIV-1 infection in a pH-dependent manner. J Virol. 2019 Feb 5;93(4):e01749-18. doi: 10.1128/JVI.01749-18. PMID: 30518643; PMCID: PMC6363989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Dalrymple N, Mackow ER.. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol. 2011;85:9478–9485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nickells J, Cannella M, Droll DA, et al. . Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model. J Virol. 2008;82:12510–12519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lee E, Lobigs M.. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol. 2002;76:4901–4911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ceballos A, Remes Lenicov F, Sabatté J, et al. . Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med. 2009;206:2717–2733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lancaster C, Pristatsky P, Hoang VM, et al. . Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1032:218–223. [DOI] [PubMed] [Google Scholar]
  • 46.Müller JA, Harms M, Schubert A, et al. . Inactivation and environmental stability of Zika virus. Emerging Infect Dis. 2016;22:1685–1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hamel R, Dejarnac O, Wichit S, et al. . Biology of Zika virus infection in human skin cells. J Virol. 2015;89:8880–8896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Miner JJ, Diamond MS.. Zika virus pathogenesis and tissue tropism. Cell Host Microbe. 2017;21:134–142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Goodfellow IG, Sioofy AB, Powell RM, et al. . Echoviruses bind heparan sulfate at the cell surface. J Virol. 2001;75:4918–4921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Riblett AM, Blomen VA, Jae LT, et al. . A haploid genetic screen identifies heparan sulfate proteoglycans supporting rift valley fever virus infection. J Virol. 2016;90:1414–1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Clausen TM, Sandoval DR, Spliid CB, et al. . SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183:1043–1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Modis Y, Ogata S, Clements D, et al. . Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427:313–319. [DOI] [PubMed] [Google Scholar]
  • 53.González-Iglesias R, Pajares MA, Ocal C, et al. . Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol. 2002;319:527–540. [DOI] [PubMed] [Google Scholar]
  • 54.Wu C, Wang S.. A pH-sensitive heparin-binding sequence from baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells. J Virol. 2012;86:484–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wettreich A, Sebollela A, Carvalho MA, et al. . Acidic pH modulates the interaction between human granulocyte-macrophage colony-stimulating factor and glycosaminoglycans. J Biol Chem. 1999;274:31468–31475. [DOI] [PubMed] [Google Scholar]
  • 56.Arteel GE, Franken S, Kappler J, et al. . Binding of selenoprotein P to heparin: characterization with surface plasmon resonance. Biol Chem. 2000;381:265–268. [DOI] [PubMed] [Google Scholar]
  • 57.Goerges AL, Nugent MA.. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem. 2003;278:19518–19525. [DOI] [PubMed] [Google Scholar]
  • 58.Gupta-Bansal R, Frederickson RC, Brunden KR.. Proteoglycan-mediated inhibition of a beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem. 1995;270:18666–18671. [DOI] [PubMed] [Google Scholar]
  • 59.Sun J, Li Y, Liu P, et al. . Study of the mechanism of protonated histidine-induced conformational changes in the Zika virus dimeric envelope protein using accelerated molecular dynamic simulations. J Mol Graph Model. 2017;74:203–214. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure_for_review_2.tif
Figure_for_review_1.tif

Articles from Emerging Microbes & Infections are provided here courtesy of Taylor & Francis

RESOURCES